A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy

• Status: Terminated
• Trial end date: 2017-06-13

Summary

The main purpose of this study is to evaluate clinical efficacy of bismuth tripotassium dicitrate (De-Nol) in combination with pantoprazole versus pantoprazole monotherapy in subjects with NSAID-induced gastropathy in 14±2 days of treatment.

• Phase: Phase 4

Details

• Lead Sponsor: Astellas Pharma Europe B.V.
• Treatments: Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Bismuth tripotassium dicitrate; Pantoprazole